Region
Singapore's 1982 hits $12.5m first close on seed fund
Singapore’s 1982 Ventures has reached a $12.5 million first close on its debut seed fund, which will focus on financial technology in Southeast Asia. The target is $15 million.
Australia's Rokt raises $325m Series E at $1.9b valuation
Tiger Global Management has led a $325 million Series E round for Australia-based e-commerce marketing technology provider Rokt.
Flipkart, Walmart invest $145m in India's Ninjacart
Walmart and Flipkart, its Indian e-commerce platform, have doubled down on local fresh produce delivery company Ninjacart with a 145 million investment.
Advent acquires China's largest medical capsule maker
Advent International has acquired a majority stake in Guangsheng Medicinal Capsule (GS Capsule), the largest medical capsule maker in China, for an undisclosed sum.
Indonesia insurance start-up Fuse raises $25m
Fuse, which claims to be Indonesia’s largest insurance technology start-up, has raised $25 million in a Series B extension. It comes within six months of a $50 million Series B featuring East Ventures.
Vision Fund 2 leads $60m Series C for India's Juspay
SoftBank Vision Fund 2 has led a $60 million Series C funding round for Juspay Technologies, an India-based financial technology start-up that specializes in digital payments.
2022 preview: Blockchain
A broader range of investors will play in the blockchain space as new applications are normalized, although regulation remains the wildcard. Developing markets will punch above their weight
2022 preview: Healthcare
Healthcare’s high-cost, rapidly digitizing profile will persist regardless of how COVID-19 plays out in the coming years. China appears set for consolidation, including in biotech
2022 preview: India tech
As India’s technology sector balloons, investors are balancing confidence about fundamentals with expectations of pushback. Both will play out in 2022 to some extent
2022 preview: Japan VC
Japanese VC is growing up fast and looking a little less homogenous in the process. A longstanding growth-stage gap is about to disappear as new actors file in
BGH makes $432m bid for Australia's Virtus Health
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
Hong Kong's Brinc raises $130m for blockchain programs
Hong Kong accelerator Brinc has raised $130 million for blockchain-related accelerator programs and a global expansion with support from Animoca Brands, a local segment leader backed by several VCs.
2022 preview: China sustainability
Green-tech investment, from electric vehicles to renewable energy, is already in the ascendency as China ponders a carbon-neutral future. Momentum is expected to grow in 2022
2022 preview: China fundraising
Investors held fire on commitments to China managers amid uncertainty over regulatory reforms. Industry participants hope the government will provide clarity, but the fear LPs won’t hurry back
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
2022 preview: SaaS
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
China supermarket chain T11 raises $100m
T11, a China-based, technology-enabled supermarket chain, has raised a $100 million Series B led by Alibaba Group. Other investors include Redview Capital and MSA Capital.
Japan's Global Brain launches two VC funds, expands global remit
Japan’s Global Brain has launched its eighth flagship VC fund, seeking JPY40 billion ($352 million) for a more international-facing mandate. It has also launched a follow-on fund targeting JPY10 billion.
Deal focus: LingoAce shakes up Chinese class
Singapore’s LingoAce is leveraging growing interest in learning the Chinese language with an entertainment-focused education platform. Sequoia Capital India is backing a global expansion
Q&A: Legend Capital's Richard Li
Richard Li, president of Legend Capital, on evolving US-China relations, the logic behind the recent wave of regulation, investing in line with government policy, and why LPs should get used to onshore exits
Deal focus: Longreach eyes long overdue EnTie exit
Mindful of how political maneuvering has undone previous sale processes of Taiwan’s EnTie Commercial Bank, The Longreach Group is on edge as regulators prepare to rule on a $1.2 billion tie-up with IBF Financial
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
China's Avistone Pharmaceuticals raises $200m
Avistone Pharmaceuticals, a Beijing biotech company focused on precision oncology therapeutics has raised more than $200 million in a Series A funding round led by Vivo Capital.